Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Pine Tree Acquisition Corp. consummated the sale of 600,000 additional units at $10.00 per unit following the partial exercise of the underwriter's over-allotment option. The transaction generated $6 million in gross proceeds, bringing the total amount held in the company's trust account to $106 million.
Blackstone Real Estate Income Trust Capital Raise of $10.3M
Blackstone Real Estate Income Trust, Inc. sold unregistered shares of its Class C common stock to investment vehicles for aggregate consideration of approximately $10.3 million. The sales occurred in two tranches on September 1 and October 1, 2026, and were conducted as private placements exempt from registration under Section 4(a)(2) and Regulation S.
The Crypto Company entered into subscription agreements to raise $75,000 through a private placement of 97,165,533 shares of common stock. The consideration consisted of $65,000 in cash and 3.4683 ETH, with one of the investors being an entity managed by the company's Chief Strategy Officer.
Greenlane Holdings' subsidiaries filed petitions in the Florida Circuit Court to commence assignment proceedings for the benefit of creditors. The court has assumed jurisdiction over the assets of Warehouse Goods LLC, Greenlane Holdings LLC, KIM International LLC, and Kush Supply Co. LLC, which will be liquidated by an assignee to pay creditors.
First Tracks Biotherapeutics Capital Raise of $200M
First Tracks Biotherapeutics entered into a securities purchase agreement for a $200 million private placement (PIPE) of 6,106,870 shares of common stock at $32.75 per share. The offering includes participation from several institutional investors and is intended to fund the clinical development of ANB033 and other general corporate purposes.
Value
$200M
Counterparty
Affinity Asset Advisors, LLC, First Light Asset Management, Sirenia Capital Management LP, TCGX, Trails Edge Capital Partners, Vestal Point Capital
Daily Journal M&A Deal with Revir Technologies, Inc.
Daily Journal Corporation completed the acquisition of Austin-based software company Revir Technologies, Inc. on October 13, 2026. Revir, which provides the Scout AI-powered digital evidence management platform for law enforcement and public safety agencies, will operate independently within Daily Journal's Courts, Justice, and Government Technology division.
Frazier Life Sciences Acquisition Corp. II Capital Raise of $78M
Frazier Life Sciences Acquisition Corp. II consummated its initial public offering (IPO) of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds. Simultaneously, the company's sponsor purchased 300,000 private placement shares for an additional $3 million, and a forward purchase agreement was established for at least $25 million to be funded at the time of a future business combination.
Stockholders of Indivior Pharmaceuticals, Inc. approved the issuance of common stock in connection with a previously announced merger agreement. The vote satisfies Nasdaq Rule 5635 requirements for the share issuance, marking a key step toward completing the acquisition.
Cyngn Inc. received a deficiency notice from Nasdaq on October 14, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days. The company has 180 calendar days, or until April 12, 2027, to regain compliance by maintaining a bid price of at least $1.00 for at least 10 consecutive business days.
Fortune Brands Innovations Divestiture to Inteplast Group Corporation for $160M
Fortune Brands Innovations has entered into a definitive agreement to sell its Fiberon composite decking business to a subsidiary of Inteplast Group Corporation for $160 million in cash. In connection with the sale, the company expects to record a non-cash impairment charge between $175 million and $205 million. The divestiture is part of a strategic review to focus resources on higher-return opportunities and is expected to close within 60 days.
Sow Good Inc. and its subsidiary entered into an extension letter to a previously announced Share Purchase Agreement with Ryzon Materials Limited and other sellers. The letter extends the 'Sunset Date' for the acquisition to October 30, 2026. This filing provides a timeline update on a pending merger/acquisition transaction.
Colony Bankcorp Signs $163M M&A Deal with First Reliance Bancshares, Inc.
Colony Bankcorp shareholders approved the issuance of common stock for the acquisition of First Reliance Bancshares, Inc. in a stock-and-cash transaction valued at approximately $163 million. The deal has received all necessary regulatory approvals and is expected to close in the fourth quarter of 2026, creating a combined entity with approximately $5 billion in total assets.
Supernus Pharmaceuticals M&A Deal with Indivior Pharmaceuticals Inc.
Supernus Pharmaceuticals stockholders approved the company's acquisition by Indivior Pharmaceuticals at a special meeting held on October 15, 2026. Under the terms of the merger agreement, Supernus will become a wholly-owned subsidiary of Indivior. Stockholders also approved, on a non-binding basis, the merger-related compensation for the company's named executive officers.
Melar Acquisition Corp. I M&A Deal with Everli Global Inc.
Melar Acquisition Corp. I provided a status update on its pending business combination with Everli Global Inc., an Italian e-grocery marketplace. The filing includes a press release from Everli outlining its asset-light business model and retail network, which includes partnerships with Italy's 13 largest grocers. Upon closing, the combined company is expected to trade on Nasdaq under the ticker EVRL.
Opko Health Divestiture to Laboratory Corporation of America Holdings for $722M
OPKO Health and its subsidiary BioReference Health entered into a definitive agreement to sell certain assets of their clinical and anatomic pathology laboratory testing business to Labcorp for $722 million in cash. The deal includes clinical and women’s health testing, urology, and the proprietary 4Kscore prostate cancer test, with OPKO eligible for up to an additional $150 million in milestone payments over ten years based on 4Kscore revenue. The transaction is subject to HSR Clearance and customary closing conditions, with a target completion date by April 14, 2027.
Innovative Eyewear received a deficiency notice from Nasdaq on October 9, 2026, because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until April 7, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
Faraday Future Intelligent Electric Divestiture to FF EAI Robotics Ecosystem Inc. for $200M
Faraday Future Intelligent Electric Inc. (FFAI) entered into a definitive agreement to sell its robotics business to FF EAI Robotics Ecosystem Inc. (FFR) for approximately $200 million in an all-stock transaction. FFAI will receive FFR common and preferred stock at a price of $2.246 per share, resulting in FFAI becoming the majority and controlling stockholder of FFR with a 65.7% stake.
Consolidated Water Co Wins $39.8M Contract from City of Pismo Beach, California
Consolidated Water's subsidiary, PERC Water Corporation, entered into a $39.8 million design-build agreement with the City of Pismo Beach for the Central Coast Blue Advanced Water Purification Facility. The project involves designing and constructing a drought-resistant water supply system using ultrafiltration and reverse osmosis, with substantial completion expected by September 2028.
Value
$39.8M
Counterparty
City of Pismo Beach, California
Term
703 calendar days
“This award reflects the strength of our advanced water-treatment capabilities and our ability to compete successfully for technically sophisticated design-build projects. We are proud that PERC Water was selected following a rigorous competitive evaluation, and we look forward to supporting the City of Pismo Beach as it advances a reliable, locally controlled, and drought-resistant water supply.”
Mustang Bio received a second 180-day grace period from Nasdaq, until April 12, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company intends to monitor its stock price and may effect a reverse stock split if necessary to maintain its listing on the Nasdaq Capital Market.
Andersen Group M&A Deal with Andersen Servicios Profesionales
Andersen Group Inc. announced the acquisition of five professional services and consulting firms: Andersen Servicios Profesionales, BD Emerson, Daniels Consulting Group, Endeavor Management, and Clareo Consulting. The transactions involve a mix of cash and the issuance of Class A common stock as consideration, with two deals already closed and three expected to close by Q1 2027.
Grayscale Stellar Lumens Trust Capital Raise of $1.14M
Grayscale Stellar Lumens Trust issued 73,400 shares in private placement transactions to accredited investors for an aggregate of approximately 6.06 million XLM, valued at $1,136,743. The shares were issued at varying prices based on the Trust's NAV per share, bringing the total shares outstanding to 1,462,600.
GM Financial Consumer Automobile Receivables Trust 2026-4 Capital Raise of $1.02B
GM Financial Consumer Automobile Receivables Trust 2026-4 completed the issuance of $1.016 billion in asset-backed notes across several classes (A-1 through C). The notes are backed by a pool of prime automobile loan contracts and were sold to a syndicate of underwriters led by SMBC Nikko Securities America.
iPower Inc. announced that its subsidiary, iPower AI LLC, received a customer-signed, non-binding letter of intent for a five-year AI equipment services and management relationship. The deal contemplates an expansion from 48 to 396 AI computing units, potentially generating up to $21.90 million in annualized service fees.
bioAffinity Technologies announced it will present positive research data at the CHEST 2026 annual meeting regarding its CyPath Lung test and a new investigational test for asthma and COPD-related lung inflammation. The presentation will focus on improving lung cancer risk stratification and managing pulmonary nodules using the company's noninvasive flow cytometry technology.
Evolution Metals & Technologies Corp. has begun taking delivery of 13 ULVAC machines at its Pohang, South Korea facility, part of a 57-container shipment to expand production. The expansion is expected to increase the company's annual rare earth magnet capacity ten-fold from 1,000 to 10,000 metric tons. This move positions EM&T as the largest producer of rare earth permanent magnets outside of China ahead of new U.S. defense procurement regulations.
Quantum-Si Incorporated has regained compliance with Nasdaq's minimum bid price requirement as its Class A common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days. The company had previously received a deficiency notice on July 23, 2026, and Nasdaq has now officially closed the matter.
Beazer Homes USA M&A Deal with Dream Finders Homes, Inc.
Beazer Homes USA stockholders approved the previously announced merger agreement with Dream Finders Homes, Inc. at a special meeting held on October 15, 2026. Under the terms of the agreement, Beazer Homes will become a wholly owned subsidiary of Dream Finders Homes, with the closing expected to occur three business days after final conditions are met.
Recursion Pharmaceuticals entered into an underwriting agreement to raise approximately $200 million through a public offering of 61,540,000 shares of Class A common stock at $3.25 per share. The company also announced that Sanofi exercised an option for a first-in-class immunology development candidate under their existing collaboration, triggering a $10 million milestone payment. Proceeds from the equity raise are expected to extend the company's cash runway into 2029.
Vivos Therapeutics Signs $12M M&A Deal with SOD Sciences, Inc.
Vivos Therapeutics entered into a definitive agreement to acquire an 11% equity stake in SOD Sciences and a 50% co-ownership interest in a proprietary pseudohypoxia early-warning test. The transaction is valued at $12 million, paid via the issuance of 12,000 shares of newly created Series C Convertible Preferred Stock, and is intended to bolster stockholders' equity for Nasdaq compliance.
AtlasClear Holdings Signs $24.5M M&A Deal with Ark Financial Services, Inc.
AtlasClear Holdings has entered into a definitive agreement to acquire Ark Financial Services, the parent of investment bank Dawson James Securities, for up to $24.5 million in cash and stock. The company concurrently completed an initial 24.9% equity purchase for $5 million, with the remaining 75.1% acquisition subject to FINRA approval and other closing conditions. The deal aims to integrate a nationally ranked small-cap investment bank into AtlasClear's clearing platform, more than doubling the company's combined pro forma revenue.